Literature DB >> 18941439

Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins.

Travis S Hughes1, Stephen J Langer, Kirk W Johnson, Raymond A Chavez, Linda R Watkins, Erin D Milligan, Leslie A Leinwand.   

Abstract

Therapeutic benefit has been reported to result from intrathecal (i.t.) injection of transgene vectors, including naked DNA. However, most studies using naked DNA have measured only the transgene expression of intracellular proteins. Here we demonstrate that i.t. injection of naked DNA can result in long-term expression of secreted proteins. Plasmids expressing either secreted alkaline phosphatase (SEAP) or human interleukin-10 (hIL-10) were injected into the i.t. space in rats, and transgene products were repeatedly measured in the cerebrospinal fluid (CSF). Both SEAP and hIL-10 were maximal at 1 and 2 days after the injection and still detectable at 4 months. The utilization of a plasmid having two features that are hypothesized to increase gene expression (matrix attachment regions (MARs) and lack of CpG dinucleotides) resulted in a significant increase in gene expression. Reinjection of SEAP or hIL-10 plasmids after 4 months significantly increased protein levels at 1 and 14 days after the reinjection. SEAP was uniformly distributed between the DNA delivery site (approximately vertebral level T13) and the lumbar puncture site (L5/L6 inter-vertebral space), was reduced at the cisterna magna, and was detectable, though at much lower levels, in serum. These data suggest that naked DNA has the potential to be used as a therapeutic tool for applications that require long-term release of transgenes into the CSF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941439      PMCID: PMC2834984          DOI: 10.1038/mt.2008.230

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  48 in total

1.  Antigen levels and antibody titers after DNA vaccination.

Authors:  M Chastain; A J Simon; K A Soper; D J Holder; D L Montgomery; S L Sagar; D R Casimiro; C R Middaugh
Journal:  J Pharm Sci       Date:  2001-04       Impact factor: 3.534

2.  Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.

Authors:  C H Miao; K Ohashi; G A Patijn; L Meuse; X Ye; A R Thompson; M A Kay
Journal:  Mol Ther       Date:  2000-06       Impact factor: 11.454

3.  Efficient nonviral cutaneous transfection.

Authors:  J Glasspool-Malone; S Somiari; J J Drabick; R W Malone
Journal:  Mol Ther       Date:  2000-08       Impact factor: 11.454

4.  Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity.

Authors:  Y Tan; F Liu; Z Li; S Li; L Huang
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

5.  Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.

Authors:  Zhi-Ying Chen; Efren Riu; Chen-Yi He; Hui Xu; Mark A Kay
Journal:  Mol Ther       Date:  2008-02-05       Impact factor: 11.454

6.  Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates.

Authors:  G Zhang; V Budker; P Williams; V Subbotin; J A Wolff
Journal:  Hum Gene Ther       Date:  2001-03-01       Impact factor: 5.695

7.  Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adeno-associated virus in zebrafish.

Authors:  C D Hsiao; F J Hsieh; H J Tsai
Journal:  Dev Dyn       Date:  2001-04       Impact factor: 3.780

8.  Interleukin-2 gene has superior antinociceptive effects when delivered intrathecally.

Authors:  Ming-Zhong Yao; Jin-Hui Wang; Jin-Fa Gu; Lan-Ying Sun; Huan Liu; Zhi-Qi Zhao; Xin-Yuan Liu
Journal:  Neuroreport       Date:  2002-05-07       Impact factor: 1.837

9.  Gene expression along the cerebral-spinal axis after regional gene delivery.

Authors:  C Meuli-Simmen; Y Liu; T T Yeo; D Liggitt; G Tu; T Yang; M Meuli; S Knauer; T D Heath; F M Longo; R J Debs
Journal:  Hum Gene Ther       Date:  1999-11-01       Impact factor: 5.695

10.  IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.

Authors:  E Butti; A Bergami; A Recchia; E Brambilla; U Del Carro; S Amadio; A Cattalini; M Esposito; A Stornaiuolo; G Comi; S Pluchino; F Mavilio; G Martino; R Furlan
Journal:  Gene Ther       Date:  2008-01-31       Impact factor: 5.250

View more
  10 in total

1.  Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound.

Authors:  Emmanuel Thévenot; Jessica F Jordão; Meaghan A O'Reilly; Kelly Markham; Ying-Qi Weng; Kevin D Foust; Brian K Kaspar; Kullervo Hynynen; Isabelle Aubert
Journal:  Hum Gene Ther       Date:  2012-10-15       Impact factor: 5.695

Review 2.  Secreted blood reporters: insights and applications.

Authors:  Bakhos A Tannous; Jian Teng
Journal:  Biotechnol Adv       Date:  2011-09-08       Impact factor: 14.227

3.  Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.

Authors:  Arden G Vanderwall; Shahani Noor; Melody S Sun; Jacob E Sanchez; Xuexian O Yang; Lauren L Jantzie; Nikolaos Mellios; Erin D Milligan
Journal:  Brain Behav Immun       Date:  2017-11-04       Impact factor: 7.217

4.  Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression.

Authors:  Travis S Hughes; Stephen J Langer; Salla I Virtanen; Raymond A Chavez; Linda R Watkins; Erin D Milligan; Leslie A Leinwand
Journal:  J Gene Med       Date:  2009-09       Impact factor: 4.565

5.  Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer.

Authors:  Abdullah Tahir Bayrac; Oya Ercan Akca; Fusun Inci Eyidogan; Huseyin Avni Oktem
Journal:  J Biosci       Date:  2018-03       Impact factor: 1.826

6.  Multiplex blood reporters for simultaneous monitoring of cellular processes.

Authors:  M Sarah S Bovenberg; M Hannah Degeling; Seyedali Hejazi; Romain J Amante; Marte van Keulen; Judith W M Jeuken; Sepideh Akbaripanahi; Carmen L A Vleggeert-Lankamp; Marie Tannous; Pieter Wesseling; Thomas Wurdinger; Bakhos A Tannous
Journal:  Anal Chem       Date:  2013-10-16       Impact factor: 6.986

Review 7.  Spinal interleukin-10 therapy to treat peripheral neuropathic pain.

Authors:  Erin D Milligan; Kathryn R Penzkover; Ryan G Soderquist; Melissa J Mahoney
Journal:  Neuromodulation       Date:  2012-06-01

8.  Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.

Authors:  Liang Jing; Wenlong Wang; Shuangshuang Zhang; Minjie Xie; Daishi Tian; Xiang Luo; Daowen Wang; Qin Ning; Jiagao Lü; Wei Wang
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

9.  Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery.

Authors:  Guangwen Li; Fei Ma; Yanping Gu; Li-Yen Mae Huang
Journal:  Mol Pain       Date:  2013-12-05       Impact factor: 3.395

10.  Viral Metagenomics on Cerebrospinal Fluid.

Authors:  Arthur W D Edridge; Martin Deijs; Ingeborg E van Zeggeren; Cormac M Kinsella; Maarten F Jebbink; Margreet Bakker; Diederik van de Beek; Matthijs C Brouwer; Lia van der Hoek
Journal:  Genes (Basel)       Date:  2019-04-30       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.